NCT00000605View on ClinicalTrials.gov

Estrogen and Graft Atherosclerosis Research Trial (EAGER)

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1996

Study Completion Date

July 31, 2002

Conditions
Cardiovascular DiseasesCoronary ArteriosclerosisCoronary DiseaseHeart DiseasesMyocardial IschemiaPostmenopause
Interventions
DRUG

hormone replacement therapy

DRUG

estrogens

DRUG

medroxyprogesterone

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00000605 - Estrogen and Graft Atherosclerosis Research Trial (EAGER) | Biotech Hunter | Biotech Hunter